Emerald Advisers LLC Has $40.76 Million Holdings in Vital Farms, Inc. $VITL

Emerald Advisers LLC trimmed its holdings in Vital Farms, Inc. (NASDAQ:VITL) by 2.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 990,625 shares of the company’s stock after selling 24,600 shares during the quarter. Vital Farms accounts for 1.3% of Emerald Advisers LLC’s portfolio, making the stock its 20th largest holding. Emerald Advisers LLC owned approximately 2.22% of Vital Farms worth $40,764,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of VITL. Exchange Traded Concepts LLC bought a new stake in Vital Farms in the 3rd quarter valued at $28,000. Assetmark Inc. raised its position in shares of Vital Farms by 18.9% during the second quarter. Assetmark Inc. now owns 3,153 shares of the company’s stock valued at $121,000 after buying an additional 501 shares during the last quarter. State of Wyoming bought a new stake in shares of Vital Farms in the second quarter valued at about $141,000. Elevation Point Wealth Partners LLC bought a new position in Vital Farms during the second quarter valued at about $178,000. Finally, Tower Research Capital LLC TRC raised its holdings in Vital Farms by 363.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,714 shares of the company’s stock valued at $182,000 after acquiring an additional 3,696 shares in the last quarter. Institutional investors own 98.59% of the company’s stock.

Insiders Place Their Bets

In related news, insider Matthew Ohayer sold 25,000 shares of Vital Farms stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $30.85, for a total value of $771,250.00. Following the completion of the transaction, the insider directly owned 6,361,190 shares of the company’s stock, valued at $196,242,711.50. The trade was a 0.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Russell Diez-Canseco sold 16,734 shares of the stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $35.05, for a total transaction of $586,526.70. Following the sale, the chief executive officer directly owned 649,684 shares in the company, valued at approximately $22,771,424.20. This represents a 2.51% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 101,734 shares of company stock valued at $3,350,177. 21.30% of the stock is currently owned by corporate insiders.

Vital Farms Price Performance

NASDAQ:VITL opened at $27.30 on Thursday. The firm has a market cap of $1.22 billion, a PE ratio of 20.68 and a beta of 1.11. The company’s 50-day moving average price is $31.58 and its two-hundred day moving average price is $38.29. The company has a quick ratio of 2.15, a current ratio of 2.65 and a debt-to-equity ratio of 0.02. Vital Farms, Inc. has a 12 month low of $26.65 and a 12 month high of $53.13.

Vital Farms (NASDAQ:VITL) last posted its earnings results on Tuesday, November 4th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.06. The company had revenue of $198.94 million during the quarter, compared to analysts’ expectations of $191.35 million. Vital Farms had a net margin of 8.50% and a return on equity of 20.19%. Vital Farms’s quarterly revenue was up 37.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.16 earnings per share. On average, equities analysts anticipate that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

VITL has been the topic of several recent research reports. TD Cowen reissued a “buy” rating on shares of Vital Farms in a report on Tuesday. Morgan Stanley decreased their price target on shares of Vital Farms from $48.00 to $45.00 and set an “overweight” rating on the stock in a research note on Wednesday, December 17th. Weiss Ratings reissued a “hold (c+)” rating on shares of Vital Farms in a report on Monday, December 29th. Jefferies Financial Group reaffirmed a “buy” rating and set a $52.00 price objective on shares of Vital Farms in a report on Wednesday, December 17th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $45.00 target price on shares of Vital Farms in a research note on Thursday, December 18th. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Vital Farms has a consensus rating of “Moderate Buy” and an average target price of $49.91.

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.